25 research outputs found
Facial asymmetry tracks genetic diversity among Gorilla subspecies
Mountain gorillas are particularly inbred compared to other gorillas and even the most inbred human populations. As mountain gorilla skeletal material accumulated during the 1970s, researchers noted their pronounced facial asymmetry and hypothesized that it reflects a population-wide chewing side preference. However, asymmetry has also been linked to environmental and genetic stress in experimental models. Here, we examine facial asymmetry in 114 crania from three Gorilla subspecies using 3D geometric morphometrics. We measure fluctuating asymmetry (FA), defined as random deviations from perfect symmetry, and population-specific patterns of directional asymmetry (DA). Mountain gorillas, with a current population size of about 1000 individuals, have the highest degree of facial FA (explaining 17% of total facial shape variation), followed by Grauer gorillas (9%) and western lowland gorillas (6%), despite the latter experiencing the greatest ecological and dietary variability. DA, while significant in all three taxa, explains relatively less shape variation than FA does. Facial asymmetry correlates neither with tooth wear asymmetry nor increases with age in a mountain gorilla subsample, undermining the hypothesis that facial asymmetry is driven by chewing side preference. An examination of temporal trends shows that stress-induced developmental instability has increased over the last 100 years in these endangered apes
Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry
Background & aims: Prospective drug-induced liver injury (DILI) registries are important sources of information on idiosyncratic DILI. We aimed to present a comprehensive analysis of 843 patients with DILI enrolled into the Spanish DILI Registry over a 20-year time period.
Methods: Cases were identified, diagnosed and followed prospectively. Clinical features, drug information and outcome data were collected.
Results: A total of 843 patients, with a mean age of 54 years (48% females), were enrolled up to 2018. Hepatocellular injury was associated with younger age (adjusted odds ratio [aOR] per year 0.983; 95% CI 0.974-0.991) and lower platelet count (aOR per unit 0.996; 95% CI 0.994-0.998). Anti-infectives were the most common causative drug class (40%). Liver-related mortality was more frequent in patients with hepatocellular damage aged âĽ65 years (p = 0.0083) and in patients with underlying liver disease (p = 0.0221). Independent predictors of liver-related death/transplantation included nR-based hepatocellular injury, female sex, higher onset aspartate aminotransferase (AST) and bilirubin values. nR-based hepatocellular injury was not associated with 6-month overall mortality, for which comorbidity burden played a more important role. The prognostic capacity of Hy's law varied between causative agents. Empirical therapy (corticosteroids, ursodeoxycholic acid and MARS) was prescribed to 20% of patients. Drug-induced autoimmune hepatitis patients (26 cases) were mainly females (62%) with hepatocellular damage (92%), who more frequently received immunosuppressive therapy (58%).The present study has been supported by grants of Instituto de Salud Carlos III cofounded by Fondo Europeo de Desarrollo Regional â FEDER (contract numbers: PI19/00883, PI16/01748, PI18/00901, PI18/01804, PI-0285-2016, PI-0274-2016, PI-0310- 2018, PT17/0017/0020) and Agencia EspaĂąola del Medicamento. CIBERehd and Plataforma ISCIII Ensayos Clinicos are funded by Instituto de Salud Carlos III. MRD holds a Joan Rodes (JR16/ 00015)/AcciĂłn B clinicos investigadores (B-0002-2019) and JSC a Rio Hortega (CM17/00243) research contract from ISCIII and ConsejerĂa de Salud de AndalucĂa. The funding sources had no involvement in the study design; in the collection, analysis, and interpretation of data; in the writing of the report or in the de- cision to submit the manuscript for publication
Bienestar y familia, una mirada desde la psicologĂa positiva
Este libro estĂĄ dirigido a estudiantes y profesionales en psicologĂa y ĂĄreas afines, como enfermerĂa, trabajo social o educaciĂłn, y a los interesados en personalidad positiva. Cada capĂtulo se presenta de manera sencilla y con una estructura didĂĄctica, pero sin perder rigor cientĂfico y calidad de la revisiĂłn, con el fin de facilitar el acceso a la informaciĂłn sobre bienestar individual, familiar y social de una forma accesible para adentrarnos al estudio de temas de psicologĂa positiva. Dadas las temĂĄticas, se considerĂł pertinente dividir este libro en dos secciones: I. PsicologĂa positiva y bienestar. II. Bienestar individual y familiar.Universidad AutĂłnoma del Estado de MĂŠxico y Ediciones y GrĂĄficos EĂłn, S.A. de C.V
SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues
Variability in SARS-CoV-2 susceptibility and COVID-19 disease severity between individuals is partly due to
genetic factors. Here, we identify 4 genomic loci with suggestive associations for SARS-CoV-2 susceptibility
and 19 for COVID-19 disease severity. Four of these 23 loci likely have an ethnicity-specific component.
Genome-wide association study (GWAS) signals in 11 loci colocalize with expression quantitative trait loci
(eQTLs) associated with the expression of 20 genes in 62 tissues/cell types (range: 1:43 tissues/gene),
including lung, brain, heart, muscle, and skin as well as the digestive system and immune system. We perform
genetic fine mapping to compute 99% credible SNP sets, which identify 10 GWAS loci that have eight or fewer
SNPs in the credible set, including three loci with one single likely causal SNP. Our study suggests that the
diverse symptoms and disease severity of COVID-19 observed between individuals is associated with variants across the genome, affecting gene expression levels in a wide variety of tissue types
Event shapes and azimuthal correlations in Z plus jets events in pp collisions at root
is produced in association with jets in protonâproton collisions. The data collected with the CMS detector at the CERN LHC at correspond to an integrated luminosity of 5.0 fb. The analysis provides a test of predictions from perturbative QCD for a process that represents a substantial background to many physics channels. Results are presented as a function of jet multiplicity, for inclusive Z boson production and for Z bosons with transverse momenta greater than 150 GeV, and compared to predictions from Monte Carlo event generators that include leading-order multiparton matrix-element (with up to four hard partons in the final state) and next-to-leading-order simulations of Z+1-jet events. The experimental results are corrected for detector effects, and can be compared directly with other QCD model
The human remains found in 1967 in Axlor: Still not convincingly Neandertals: A reply to Gonzalez-Urquijo et al
Differential iNKT and T Cells Activation in Non-Alcoholic Fatty Liver Disease and Drug-Induced Liver Injury.
Non-alcoholic fatty liver disease (NAFLD) and idiosyncratic drug-induced liver injury (DILI) could share molecular mechanisms involving the immune system. We aimed to identify activation immunological biomarkers in invariant natural killer T (iNKT) and CD4/CD8+ T cells in NAFLD and DILI. We analyzed the activation profile (CD69, CD25, and HLA-DR) and natural killer group 2 member D (NKG2D) on iNKT cells, and CD4/CD8 T cells in peripheral blood mononuclear cells from NAFLD, with or without significant liver fibrosis, and DILI patients. There was an increase in iNKT cells in NAFLD patients compared to DILI or control subjects. Regarding the cellular activation profile, NAFLD with significant liver fibrosis (F ⼠2) displayed higher levels of CD69+iNKT cells compared to NAFLD with none or mild liver fibrosis (F ⤠1) and control patients. CD69+iNKT positively correlated with insulin resistance, aspartate aminotransferase (AST) level, liver fibrosis-4 index (FIB4) and AST to Platelet Ratio Index (APRI). DILI patients showed an increase in CD69+ and HLA-DR+ in both CD4+ and CD8+ T cells, detecting the most relevant difference in the case of CD69+CD8+ T cells. CD69+iNKT may be a biomarker to assess liver fibrosis progression in NAFLD. CD69+CD8+ T cells were identified as a potential distinctive biomarker for distinguishing DILI from NAFLD
Definition and risk factors for chronicity following acute idiosyncratic drug-induced liver injury.
Chronic outcome following acute idiosyncratic drug-induced liver injury (DILI) is not yet defined. This prospective, long-term follow-up study aimed to analyze time to liver enzyme resolutions to establish the best definition and risk factors of DILI chronicity. 298 out of 850 patients in the Spanish DILI registry with no pre-existing disease affecting the liver and follow-up to resolution or ⊞1year were analyzed. Chronicity was defined as abnormal liver biochemistry, imaging test or histology one year after DILI recognition. Out of 298 patients enrolled 273 (92%) resolved ⊽1year from DILI recognition and 25 patients (8%) were chronic. Independent risk factors for chronicity were older age [OR: 1.06, p=0.011], dyslipidemia [OR: 4.26, p=0.04] and severe DILI [OR: 14.22, p=0.005]. Alanine aminotransferase (ALT), alkaline phosphatase (ALP) and total bilirubin (TB) median values were higher in the chronic group during follow-up. Values of ALP and TB >1.1 x upper limit of normal (xULN) and 2.8 xULN respectively, in the second month from DILI onset, were found to predict chronic DILI (p1.1 x upper limit of normal (xULN) and 2.8 xULN respectively, in the second month from DILI onset, were found to predict chronic DILI (p One year is the best cut-off point to define chronic DILI or prolonged recovery, with risk factors being older age, dyslipidemia and severity of the acute episode. Statins are distinctly related to chronicity. ALP and TB values in the second month could help predict chronicity or very prolonged recovery. Drug-induced liver injury (DILI) patients who do not resolve their liver damage during the first year should be considered chronic DILI patients. Risk factors for DILI chronicity are older age, dyslipidemia and severity of the acute episode. Chronic DILI is not a very common condition; normally featuring mild liver profile abnormalities and not being an important clinical problem, with the exception of a small number of cases of early onset cirrhosis
AdecuaciĂłn del primer curso de los estudios de InformĂĄtica al Espacio Europeo de EducaciĂłn Superior
A measurement of the Lambda(0)(b) lifetime using the decay Lambda(0)(b) -> J/psi Lambda in protonproton collisions at root s = 7TeV is presented. The data set, corresponding to an integrated luminosity of about 5 fb(-1), was recorded with the CMS experiment at the Large Hadron Collider using triggers that selected dimuon events in the J/psi mass region. The Lambda(0)(b) lifetime is measured to be 1.503 +/- 0.052 (stat.) +/- 0.031 (syst.) psBMWF ; FWF ; FNRS ; FWO ; CNPq ; CAPES ; FAPERJ ; FAPESP ; MEYS ; CERN ; CAS ; MoST ; NSFC ; COLCIENCIAS ; MSES ; RPF ; MoER ; SF0690030s09 ; ERDF ; Academy of Finland ; MEC ; HIP ; CEA ; CNRS/IN2P3 ; BMBF ; DFG ; HGF ; GSRT ; OTKA ; NKTH ; DAE ; DST ; IPM ; SFI ; INFN ; NRF ; WCU ; LAS ; CINVESTAV ; CONACYT ; SEP ; UASLP-FAI ; MSI ; PAEC ; MSHE ; NSC ; FCT ; JINR ; MON ; RosAtom ; RAS ; RFBR ; MSTD ; SEIDI ; CPAN ; Swiss Funding Agencies ; NSC ; ThEPCenter ; IPST ; NSTDA ; TUBITAK ; TAEK ; NASU ; STFC ; University of California Institute for Mexico and the United States ; the Marie-Curie programme and the European Research Council and EPLANET ; DOE and NSF ; the Leventis Foundation ; the A. P. Sloan Foundation ; the Alexander von Humboldt Foundation ; the Belgian Federal Science Policy Office ; the Fonds pour la Formation Ă la Recherche dans lâIndustrie et dans lâAgriculture ; the Agentschap voor Innovatie door Wetenschap en Technologie ; the Ministry of Education ; Youth and Sports of Czech Republic ; the Agence Nationale de la Recherche ANR-12-JS05-002-01 ; the Council of Science and Industrial Research ; India; the Compagnia di San Paolo ; the HOMING PLUS programme of Foundation for Polish Science cofinanced by EU ; Regional Development Fund ; the Thalis and Aristeia programmes cofinanced by EU-ESF and the Greek NSRF.